恩华药业,002262,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),902,124,778,86.23%,0.63% 原料药,4114,2723,1391,33.82%,1.12% 精神类,50774,8622,42152,83.02%,34% 商业,71602,63788,7814,10.91%,6.3% 神经类,7550,1631,5919,78.39%,4.77% 其他贸易及劳务,1685,1124,561,33.29%,0.45% 其他制剂,5381,2068,3313,61.57%,2.67% 麻醉类,67715,5656,62058,91.65%,50.05% 恩华药业,002262,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他贸易及劳务,3070,2439,631,20.54%,0.29% 商业医药,138111,127008,11102,8.04%,5.13% 神经类,12683,3342,9341,73.65%,4.31% 其他(补充),1996,353,1643,82.33%,0.76% 原料药,7450,2343,5107,68.55%,2.36% 精神类,86671,16671,70000,80.77%,32.32% 其他制剂,10657,2502,8155,76.52%,3.76% 麻醉类,125179,14542,110637,88.38%,51.08% 恩华药业,002262,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他贸易及劳务,2042,1719,323,15.81%,0.33% 其他制剂,5259,2201,3058,58.14%,3.09% 商业,69479,64749,4730,6.81%,4.78% 其他(补充),717,122,595,82.94%,0.6% 麻醉类,57883,6234,51649,89.23%,52.2% 神经类,5597,1385,4212,75.26%,4.26% 原料药,4468,3091,1377,30.83%,1.39% 精神类,41123,8116,33007,80.26%,33.36% 恩华药业,002262,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1317,395,922,70.02%,0.57% 其他贸易及劳务,5063,4511,552,10.91%,0.34% 商业医药,147980,139153,8828,5.97%,5.42% 原料药,6119,2841,3278,53.57%,2.01% 其他制剂,9809,3316,6494,66.2%,3.99% 神经类,9477,2282,7195,75.92%,4.42% 精神类,70047,13768,56279,80.34%,34.57% 麻醉类,89554,10318,79237,88.48%,48.68% 恩华药业,002262,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 神经类,4208,1147,3060,72.73%,3.64% 麻醉类,44833,5852,38981,86.95%,46.41% 精神类,32287,6257,26030,80.62%,30.99% 商业,75708,65904,9804,12.95%,11.67% 其他(补充),605,95,510,84.33%,0.61% 其他制剂,4978,1958,3019,60.66%,3.6% 原料药,5187,2608,2579,49.72%,3.07% 恩华药业,002262,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1910,258,1652,86.49%,1.19% 商业医药,140907,128758,12149,8.62%,8.73% 原料药,6470,4963,1507,23.29%,1.08% 其他制剂,8815,4952,3862,43.82%,2.78% 神经类,8018,2245,5773,72%,4.15% 精神类,56994,12945,44049,77.29%,31.67% 麻醉类,78664,8564,70100,89.11%,50.4% 恩华药业,002262,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),959,117,842,87.8%,1.3% 商业,68167,64666,3501,5.14%,5.39% 原料药,3397,2402,995,29.3%,1.53% 其他制剂,4316,2600,1716,39.76%,2.64% 神经类,3742,1575,2168,57.92%,3.34% 精神类,29218,7436,21782,74.55%,33.55% 麻醉类,41669,7753,33916,81.39%,52.24% 恩华药业,002262,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他业务,3380,224,3157,93.38%,2.72% 商业医药,129074,122449,6625,5.13%,5.72% 原料药,5826,5051,775,13.3%,0.67% 其他制剂,10879,7642,3237,29.76%,2.79% 神经类,6685,1930,4755,71.13%,4.1% 精神类,50789,12792,37997,74.81%,32.79% 麻醉类,70023,10694,59329,84.73%,51.2% 恩华药业,002262,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 麻醉类,31252,5159,26092,83.49%,47.45% 原料药,6507,4824,1683,25.87%,3.06% 精神类,25336,5102,20234,79.86%,36.8% 商业医药,63450,60800,2649,4.18%,4.82% 神经类,3271,1408,1863,56.96%,3.39% 其他(补充),929,80,849,91.4%,1.54% 其他制剂,3687,2068,1619,43.92%,2.94% 恩华药业,002262,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 精神类,44340,11570,32770,73.91%,32.98% 原料药,10569,9045,1524,14.42%,1.53% 商业,118564,112277,6287,5.3%,6.33% 神经类,5388,1941,3447,63.97%,3.47% 其他(补充),1388,195,1193,85.93%,1.2% 其他,9141,5454,3687,40.33%,3.71% 麻醉类,60746,10284,50461,83.07%,50.78% 恩华药业,002262,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),586,-- ,-- ,--,0% 商业医药,59187,55501,3686,6.23%,7.8% 原料药,7058,5951,1107,15.68%,2.34% 其他制剂,2579,1541,1038,40.24%,2.19% 神经类,2387,1063,1323,55.45%,2.8% 精神类,21521,4630,16891,78.49%,35.72% 麻醉类,28499,5262,23237,81.53%,49.15% 恩华药业,002262,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),955,-- ,-- ,--,0% 商业医药,113713,107207,6506,5.72%,7.33% 原料药,6131,4773,1358,22.15%,1.53% 其他制剂,9194,7017,2177,23.68%,2.45% 神经类,4581,1305,3276,71.52%,3.69% 精神类,38056,7307,30749,80.8%,34.62% 麻醉类,50978,6238,44741,87.76%,50.38% 恩华药业,002262,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),402,-- ,-- ,--,0% 商业医药,54584,50860,3724,6.82%,8.77% 原料药,3711,2819,891,24.02%,2.1% 其他制剂,5231,4115,1116,21.34%,2.63% 神经类,1587,632,956,60.2%,2.25% 精神类,18887,3660,15227,80.62%,35.84% 麻醉类,23500,2931,20569,87.53%,48.42% 恩华药业,002262,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),821,-- ,-- ,--,0% 商业医药,106697,100331,6367,5.97%,8.5% 原料药,5495,4470,1025,18.65%,1.37% 其他制剂,7357,5368,1989,27.03%,2.65% 神经类,4093,1231,2862,69.93%,3.82% 精神类,31095,6042,25054,80.57%,33.45% 麻醉类,42691,5080,37612,88.1%,50.21% 恩华药业,002262,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 原料药,3582,2958,624,17.43%,1.77% 其他(补充),361,-- ,-- ,--,0% 神经类,1475,608,867,58.79%,2.45% 麻醉类,19499,2646,16853,86.43%,47.68% 精神类,15241,2926,12315,80.8%,34.84% 商业医药,53004,49309,3695,6.97%,10.45% 其他制剂,3255,2261,994,30.53%,2.81% 恩华药业,002262,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),865,-- ,-- ,--,0% 商业医药,85703,79772,5931,6.92%,10.01% 原料药,4978,4290,687,13.81%,1.16% 其他制剂,5100,3482,1618,31.72%,2.73% 神经类,3453,921,2531,73.32%,4.27% 精神类,24880,4825,20055,80.61%,33.85% 麻醉类,33772,5353,28419,84.15%,47.97% 恩华药业,002262,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),398,-- ,-- ,--,0% 商业医药,41785,38615,3170,7.59%,11.04% 原料药,3197,2735,462,14.46%,1.61% 其他制剂,2346,1632,714,30.44%,2.49% 神经类,1719,660,1059,61.59%,3.69% 精神类,12538,2409,10129,80.79%,35.28% 麻醉类,15599,2425,13174,84.46%,45.89% 恩华药业,002262,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 商业医药,69672,65581,4091,5.87%,8.37% 原料药,4048,3489,559,13.8%,1.14% 其他制剂,3050,1702,1348,44.2%,2.76% 神经类,2914,804,2110,72.41%,4.32% 精神类,21007,4027,16980,80.83%,34.73% 麻醉类,28528,4730,23798,83.42%,48.68% 恩华药业,002262,收入构成,报告日期,2010-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 精神类,10808,2110,8697,80.48%,35.93% 麻醉类,13765,2184,11580,84.13%,47.84% 神经类,1473,591,882,59.89%,3.64% 原料药,2264,1955,309,13.65%,1.28% 商业医药,33646,31454,2192,6.52%,9.06% 其他制剂,1273,730,544,42.7%,2.25% 恩华药业,002262,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 商业医药,58538,54767,3772,6.44%,8.79% 原料药,4019,2893,1127,28.03%,2.62% 其他制剂,3398,1646,1752,51.55%,4.08% 神经类,2716,722,1994,73.41%,4.65% 精神类,18515,3566,14949,80.74%,34.83% 麻醉类,23317,3986,19332,82.91%,45.04% 恩华药业,002262,收入构成,报告日期,2009-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 商业医药,28651,26691,1960,6.84%,9.15% 原料药,1998,1537,461,23.08%,2.15% 其他制剂,1726,823,904,52.34%,4.22% 神经类,1477,467,1010,68.41%,4.71% 精神类,9490,1863,7627,80.37%,35.59% 麻醉类,11496,2027,9468,82.37%,44.18% 恩华药业,002262,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 商业医药,50906,47223,3683,7.23%,10.26% 原料药,4501,3099,1402,31.15%,3.91% 其他制剂,3788,2044,1745,46.06%,4.86% 神经类,2361,552,1809,76.64%,5.04% 精神类,15558,3282,12276,78.91%,34.22% 麻醉类,17878,2914,14964,83.7%,41.71% 恩华药业,002262,收入构成,报告日期,2007-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他收入,135,21,114,84.56%,0.38% 租赁收入,23,33,-11,-46.42%,-0.04% 商业医药,45542,42108,3434,7.54%,11.6% 原料药,3581,2441,1140,31.83%,3.85% 其他制剂,3905,2056,1849,47.36%,6.25% 神经类,1802,274,1528,84.78%,5.16% 精神类,11148,2278,8870,79.57%,29.97% 麻醉类,14347,1673,12674,88.34%,42.82% 恩华药业,002262,收入构成,报告日期,2006-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 租赁收入,49,21,28,56.45%,0.12% 商业医药,40503,37367,3136,7.74%,13.87% 原料药,2997,2243,754,25.16%,3.33% 其他制剂,4221,3145,1075,25.48%,4.75% 神经类,2178,650,1528,70.17%,6.76% 精神类,9043,1912,7131,78.86%,31.53% 麻醉类,10593,1628,8966,84.64%,39.64% 恩华药业,002262,收入构成,报告日期,2005-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他收入,26,26,0,0%,0% 材料销售收入,10,-- ,-- ,--,0% 租赁收入,1,-- ,-- ,--,0% 商业医药,36657,33543,3115,8.5%,14.53% 原料药,2401,1668,733,30.51%,3.42% 其他制剂,5279,3299,1980,37.51%,9.24% 神经类,2313,503,1810,78.25%,8.45% 精神类,7540,2070,5470,72.55%,25.53% 麻醉类,9657,1335,8322,86.17%,38.84%